Renal Effects of Aspirin - Clinical Pharmacology PDF
Document Details
Uploaded by CleanlyBoston
Mansoura
Tags
Related
- The Leadership Challenge: How to Make Extraordinary Things Happen in Organizations PDF
- Case Study: Aspirin Overdose PDF
- Comprehensive Executive Protection Course PDF
- Activity 1-Drawing 2D Structures (Step-by-Step) PDF
- Anti-inflammatory and Antigout Drugs Chapter 44 PDF
- Synthesis Of Aspirin Practical Lab PDF
Summary
This document discusses the renal effects of aspirin, including analgesic nephropathy, salt and water retention, and effects on uric acid excretion. It also covers metabolic and uterine effects, and therapeutic uses of salicylates.
Full Transcript
Renal e effects: – Anaalgesic neephropathyy: it is cchronic re enal Aspirin in a dose of 75- failu ure due to chronic abuse o of analgessics,...
Renal e effects: – Anaalgesic neephropathyy: it is cchronic re enal Aspirin in a dose of 75- failu ure due to chronic abuse o of analgessics, 150mg is not thought to which produc ce chronicc renal ischhemia duee to have a signnificant effe ect on deccrease syntthesis of reenal PGE2 and PGI2. plasma uraate levels - the – Saltt and wateer retentionn: due to d decrease RBF R British Socciety for Rheu- R matology recommen nd it andd increase aldosteron ne should be continued if re- – Antaagonize diuretic d efffect of d diuretics and quired for cardiovas scular antiihypertensive effects s of β-blocckers: due e to prophylaxiss. deccrease syntthesis of PGE P 2. – Uricc acid excrretion: smaall-to-mode erate doses of asppirin can ↓ uric u acid ex xcretion andd thus con ntraindicate ed in patiennts with gouut. Metabo olic effectts: – High doses cause c oupling of oxidative phosphorrylation → tachycard unco dia and hyp perpyrexia. Uterus s: – Prolongation of pregnancy and d delay of labo or due to inhibition of o PGs nec cessary for uterrine contra action during labor. T The use of NSAAIDs after 20 weeks of pregna ancy is not recoommended d. Therap peutic use es of salicy ylates As analgesicc and anttipyretic: in mild-to-- mooderate paiin e.g. hea adache, art rthritis, etc. It should notn be used rou utinely as s antipyretic be ecause fevver may bee a norma al pro otective meechanism. As anti-inflam mmatory and a anti-rrheumatic c: in rheumatic c fever, rheumatoid r d arthritis, osteoarthritis, etc. As antithrom mbotic: see box. 125 As keratolytic and counter-irritant: – Salicylic acid has keratolytic action and is used for treatment of warts. – Methylsalicylic acid is used as a counter-irritant for local rheumatic pain. Adverse effects of salicylates GIT: – Epigastric pain, nausea and vomiting. – Acute and chronic gastric ulcers (why?). Hepatic: – Mild reversible hepatic injury in adults. – Severe hepatic injury in children: “Reye’s syndrome”. Kidney: – Analgesic nephropathy (why?). – Salt and water retention. – ↓ the diuretic effect of loop diuretics and antihypertensive effects of β-blockers (why?). – Precipitation of acute gout in hyperurecemic patients. Blood: – Increase bleeding tendency: (why?). – Displacement of other drugs from plasma proteins. Uterus: – Prolongation of pregnancy and delay of labor (why?). Hypersensitivity – Bronchospasm (aspirin asthma) in patients with history of reactions: asthma or allergic rhinitis due to accumulation of LTs. Precautions and contraindications GIT disorders: peptic ulcer, gastritis, hemorrhagic pancreatitis, etc. Hemorrhagic disorders: hemophilia, thrombocytopenia, etc. Chronic renal diseases: aspirin may aggravate renal failure Chronic liver diseases: (those patients have bleeding tendency). Uncontrolled hypertension: risk of fatal bleeding. Gout: small-to moderate doses may inhibit uric acid excretion. Before surgery: aspirin must be stopped at least 7 days before surgery. Children 100 mg/dl). █ OTHER NSAIDS Diclofenac – One of the most widely used NSAIDs. – Generally, it is less gastric irritant than other NSAIDs but more nephrotoxic. A dose of 150 mg/day can impair renal blood flow and GFR. – It is often combined with PGE analogue misoprostol to decrease gastric ulceration. – Topical gel is available for local rheumatic pain and osteoarthritis of the knee and hands. Sulindac and ketorolac – Both have minimal effect on platelet aggregation. – Sulindac is a prodrug and has long t½. – Ketorolac is a potent analgesic but it can cause severe GIT bleeding. Ibuprofen, fenoprofen, ketoprofen – They have no reported interactions with oral anticoagulants – Ibuprofen is a good alternative to aspirin in children with flu fevers. – Fenoprofen has been reported to induce nephrotoxic syndrome – Long-term use of ibuprofen is associated with an increased incidence of hypertension in women. 127 Indom methacin – It iss a very po otent COX inhibitor b but relaatively moore toxic than oth her NSA AIDs. – It iss approved d to speed the closu ure of patent ductus d arrteriosus in prem mature infants (othherwise it is not used in children); c itt inhibits tthe prod duction of PGs wh hich preve ent clossure of the e ductus. Piroxic cam – It haas long t½ ½ (~ 45 hours). – Likee aspirin and indomethaccin, bleeeding and d ulceratio on are mo ore likely with piro oxicam thaan with oth her NSA AIDs. ▌Sele ective CO OX-2 inhibitors: Celeco oxib, etoric coxib, me eloxicam Selectivve COX-2 inhibitors s are newe er forms of NSAIDss that dire ectly targe et COX-2 enzyme e respon nsible fo or mation and inflamm d pain. Celecoxib iis approxximately 30 0 times more m potennt at inhhibiting COX-2 tha an COX-1 1. Meloxiccam is slightly s se elective foor COX-2 than COX X-1 enzyme e. Seleectivity forr COX-2 re educes th he risk of peptic ulc ceration bu ut does no ot seem tto affect other o adveerse-effectts of NSA AIDs (espec cially the risk r of renaal failure).. Selectivve COX-2 2 inhibitorrs may also incrrease the e risk o of cardiov vascular accidents a s (myocard d- ial infa arction, thrrombosis and a strokee) due to relative in ncrease in TXA2 and platelet ag ggregation n (TXA2 is fformed by COX-1 where PGI2 is formed by b COX-2 ). Rofeco oxib (Vioxxx®) and valdecoxib b were withdraawn from the t market in 2004 an nd 2005 re espectively y because of these potential p adverse e effects. 128 Non-selective COX inhibitors Selective COX-2 inhibitors Mechanism: They inhibit COX-1 (non- They inhibit COX-2 inducible) and COX-2 (inducible) enzyme only (inducible) enzymes Pharmacological Both classes have equal analgesic and antipyretic effects effects: Gastric side effects: Frequent Less frequent Renal side effects: Frequent Frequent Thrombotic Decreased Increased complications: (due to decreased platelet (due to increased platelet aggregation) aggregation) Hypersensitivity Frequent Less frequent reactions: 129